Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy

AF Abdel-Wahab, W Mahmoud, RM Al-Harizy - Pharmacological research, 2019 - Elsevier
Most solid tumor cells adapt to their heterogeneous microenvironment by depending largely
on aerobic glycolysis for energy production, a phenomenon called the Warburg effect, which …

[HTML][HTML] Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation

V Huber, C Camisaschi, A Berzi, S Ferro… - Seminars in cancer …, 2017 - Elsevier
The link between cancer metabolism and immunosuppression, inflammation and immune
escape has generated major interest in investigating the effects of low pH on tumor …

Unraveling tumor microenvironment of small-cell lung cancer: Implications for immunotherapy

T Li, T Qiao - Seminars in cancer biology, 2022 - Elsevier
Small-cell lung cancer (SCLC) is an aggressive lung cancer subtype and its first-line
treatment has remained unchanged for decades. In recent years, immunotherapy has …

Causes, consequences, and therapy of tumors acidosis

SR Pillai, M Damaghi, Y Marunaka… - Cancer and Metastasis …, 2019 - Springer
While cancer is commonly described as “a disease of the genes,” it is also associated with
massive metabolic reprogramming that is now accepted as a disease “Hallmark.” This …

Epithelial–mesenchymal transition: a new target in anticancer drug discovery

F Marcucci, G Stassi, R De Maria - Nature reviews Drug discovery, 2016 - nature.com
The conversion of cells with an epithelial phenotype into cells with a mesenchymal
phenotype, referred to as epithelial–mesenchymal transition, is a critical process for …

[HTML][HTML] Tumor-derived exosomes in cancer progression and treatment failure

S Yu, H Cao, B Shen, J Feng - Oncotarget, 2015 - ncbi.nlm.nih.gov
Exosomes have diameter within the range of 30-100nm and spherical to cup-shaped
nanoparticles with specific surface molecular characteristics, such as CD9 and CD63. These …

Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer

BY Wang, J Zhang, JL Wang, S Sun, ZH Wang… - Journal of Experimental …, 2015 - Springer
Background Acidity is a hallmark of malignant tumor, representing a very efficient
mechanism of chemoresistance. Proton pump inhibitors (PPI) at high dosage have been …

[HTML][HTML] Proton channels and exchangers in cancer

EP Spugnini, P Sonveaux, C Stock… - … et Biophysica Acta (BBA …, 2015 - Elsevier
Although cancer is characterized by an intratumoral genetic heterogeneity, a totally
deranged pH control is a common feature of most cancer histotypes. Major determinants of …

Mesenchymal stroma: role in osteosarcoma progression

M Cortini, S Avnet, N Baldini - Cancer Letters, 2017 - Elsevier
The initiation and progression of malignant tumors are supported by their microenvironment:
cancer cells per se cannot explain growth and formation of the primary or metastasis, and a …

Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy

S Fais, G Venturi, B Gatenby - Cancer and Metastasis Reviews, 2014 - Springer
Much effort is currently devoted to developing patient-specific cancer therapy based on
molecular characterization of tumors. In particular, this approach seeks to identify driver …